Company
Peroxitech
Discovering New Medications to Save and Improve Life
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for treating acute lung injury.
Funding snapshot
- Latest round
- Grant2022-08-30
Funding rounds
- Grant
- 2022-08-30
- Grant
- 2020-06-01
Loading relationship preview